Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat… EP News Bureau Mar 27, 2021 Abecma is a first-in-class BCMA-directed personalised immune cell therapy delivered as a one-time infusion for triple-class…
